Skip to results
Modify your search
NARROW
1-20 of 28
Authors: Lale Tokgozoglu
Journal Article
The Year in Cardiovascular Medicine 2024: the top 10 papers in dyslipidaemias
European Heart Journal, Volume 46, Issue 15, 14 April 2025, Pages 1412–1414, https://doi.org/10.1093/eurheartj/ehaf077
Published: 19 February 2025
Journal Article
Can apoA-I infusion decrease cardiovascular events? Get access
European Heart Journal, Volume 45, Issue 47, 14 December 2024, Pages 5039–5041, https://doi.org/10.1093/eurheartj/ehae774
Published: 09 November 2024
Journal Article
In memoriam: Akira Endo Get access
European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3199–3200, https://doi.org/10.1093/eurheartj/ehae470
Published: 22 August 2024
Journal Article
The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias
European Heart Journal, Volume 45, Issue 7, 14 February 2024, Pages 504–506, https://doi.org/10.1093/eurheartj/ehad837
Published: 28 December 2023
Journal Article
Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid lowering
European Heart Journal, Volume 44, Issue 48, 21 December 2023, Pages 5018–5020, https://doi.org/10.1093/eurheartj/ehad682
Published: 08 November 2023
Journal Article
Disconnect between triglyceride reduction and cardiovascular outcomes: lessons from the PROMINENT and CLEAR Outcomes trials
European Heart Journal, Volume 45, Issue 27, 14 July 2024, Pages 2377–2379, https://doi.org/10.1093/eurheartj/ehad485
Published: 04 November 2023
Journal Article
Glycerol and β-hydroxybutyrate: friends or foes?
European Heart Journal, Volume 44, Issue 39, 14 October 2023, Pages 4183–4185, https://doi.org/10.1093/eurheartj/ehad368
Published: 14 August 2023
Journal Article
Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers
European Heart Journal, Volume 44, Issue 25, 1 July 2023, Pages 2292–2304, https://doi.org/10.1093/eurheartj/ehad275
Published: 01 June 2023
Journal Article
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias
European Heart Journal, Volume 44, Issue 4, 21 January 2023, Pages 256–258, https://doi.org/10.1093/eurheartj/ehac750
Published: 02 January 2023
Journal Article
The year in cardiovascular medicine 2021: dyslipidaemia
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 807–817, https://doi.org/10.1093/eurheartj/ehab875
Published: 03 February 2022
Journal Article
EDITOR'S CHOICE
The dawn of a new era of targeted lipid-lowering therapies
European Heart Journal, Volume 43, Issue 34, 7 September 2022, Pages 3198–3208, https://doi.org/10.1093/eurheartj/ehab841
Published: 20 January 2022
Journal Article
GUIDELINES
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
European Heart Journal, Volume 42, Issue 34, 7 September 2021, Pages 3227–3337, https://doi.org/10.1093/eurheartj/ehab484
Published: 30 August 2021
Journal Article
Redefining cardiovascular risk prediction: is the crystal ball clearer now?
European Heart Journal, Volume 42, Issue 25, 1 July 2021, Pages 2468–2471, https://doi.org/10.1093/eurheartj/ehab310
Published: 13 June 2021
Journal Article
Can EPA evaporate plaques?
European Heart Journal, Volume 41, Issue 40, 21 October 2020, Pages 3933–3935, https://doi.org/10.1093/eurheartj/ehaa750
Published: 04 November 2020
Journal Article
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
European Heart Journal, Volume 41, Issue 24, 21 June 2020, Pages 2313–2330, https://doi.org/10.1093/eurheartj/ehz962
Published: 13 February 2020
Journal Article
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
European Heart Journal, Volume 41, Issue 1, 1 January 2020, Pages 111–188, https://doi.org/10.1093/eurheartj/ehz455
Published: 31 August 2019
Journal Article
Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
European Heart Journal, Volume 39, Issue 27, 14 July 2018, Pages 2526–2539, https://doi.org/10.1093/eurheartj/ehy182
Published: 27 April 2018
Journal Article
New prospects for PCSK9 inhibition? Get access
European Heart Journal, Volume 39, Issue 27, 14 July 2018, Pages 2600–2601, https://doi.org/10.1093/eurheartj/ehy147
Published: 22 March 2018
Journal Article
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia Get access
European Heart Journal, Volume 39, Issue 14, 07 April 2018, Pages 1131–1143, https://doi.org/10.1093/eurheartj/ehx549
Published: 16 October 2017
Journal Article
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
European Heart Journal, Volume 38, Issue 32, 21 August 2017, Pages 2459–2472, https://doi.org/10.1093/eurheartj/ehx144
Published: 24 April 2017
